I'm sure you will be able to read through many clinical studies/trials in the future.
https://www.bloomberg.com/news/artic...grown-cannabis
"The technology’s application to the cannabis industry is clear, said Gorenstein. For example, a compound called tetrahydrocannabivarin, or THCV, acts as an appetite suppressant, potentially offsetting the “munchies” effect of pot. It appears in very small quantities in the cannabis plant, making it difficult and expensive to produce at scale. Using Ginkgo’s technology, pure THCV can be produced in a lab."
“Being able to consistently and efficiently produce high-purity cannabinoids, that’s the holy grail,” Gorsenstein said."
Mike Gorenstein is CEO of Cronos and is intelligent imo. Cronos is one of the LPs that hasn't directed all their resources to grow capacity, but are attempting to secure bioceutical(?) IP.
https://www.newswire.ca/news-release...693130791.html
https://canopy-health.ca/
"One of his companies, Canopy Health, filed 27 patents in the final months of 2017. Among the conditions the company hopes to conquer are insomnia, nervous system disorders and pain management. The company is even looking into veterinary products for pets.
Linton pegs the value of the world medical marijuana market at around $180 billion."
I'm not one to say its completely viable, but I smoke dope and have tried both highly concentrated THC and CBD strains and there are definitely noticeable effects that I think could be isolated.
Hemp will also play a role in all of this.
Last edited by As1an1nvas1on; 10-26-2018 at 10:58 PM.